SCHEMBL23870613

SCHEMBL23870613

c1ccc(N2CNc3cccc4cccc2c34)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.39
▸ MEN1 O00255 7/20 0.37
▸ KDM4E B2RXH2 7/20 0.37
▸ MAPT P10636 6/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ GAA P10253 4/20 0.37
▸ APAF1 O14727 2/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ NPC1 O15118 2/20 0.35
▸ HPGD P15428 2/20 0.34
▸ RAD52 P43351 1/20 0.34
▸ NR4A1 P22736 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ APP P05067 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SNCA P37840 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ HTR7 P34969 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9154371 0.82 BRPF1 (0.39) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL23870655 0.74 ALDH1A1 (0.50) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL21368249 0.74 KDM4E (0.55) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL6934957 0.70 KMT2A (0.39) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL3205515 0.69 HSD17B10 (0.46) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL23431262 0.69 MEN1 (0.44) KMT2AMEN1ALDH1A1L3MBTL1NPC1
SCHEMBL21020694 0.69 ALDH1A1 (0.42) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL8972507 0.68 KMT2A (0.41) KMT2AMEN1KDM4EMAPTALDH1A1
SCHEMBL8756210 0.68 KMT2A (0.43) KMT2AMEN1KDM4EMAPTALDH1A1
Naphthalene SCHEMBL10492081 0.67 NPC1 (0.48) KMT2AMEN1KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230157171-A1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-05-18 — — US disclosed
US-20230157171-A1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-05-18 — — US disclosed
WO-2021191183-A1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-09-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157171-A1 CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES OR10J3, CYCS, VDAC2 KMT2A 2732/4885MEN1 2222/4885KDM4E 2326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback